The invention relates to spiro derivatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.
申请公布号
EP2861594(B1)
申请公布日期
2016.08.24
申请号
EP20130725439
申请日期
2013.05.22
申请人
CONVERGENCE PHARMACEUTICALS LIMITED
发明人
GIBLIN, GERARD M P;MACPHERSON, DAVID T;WITTY, DAVID R;STANWAY, STEVEN J
